cMET inhibitors

Details for Australian Patent Application No. 2009281822 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Bressi, Jerome C.; Chu, Shaosong; Erickson, Philip; Komandla, Mallareddy; Kwok, Lily; Lawson, John D.; Stafford, Jeffrey A.; Wallace, Michael B.; Zhang, Zhiyuan; Das, Sanjib

Agent Griffith Hack

Pub. Number AU-A-2009281822

PCT Pub. Number WO2010/019899

Priority 61/161,007 17.03.09 US; 61/088,959 14.08.08 US; 61/117,910 25.11.08 US

Filing date 14 August 2009

Wipo publication date 18 February 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/019899 Priority application(s): WO2010/019899

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281823-Multiphase drilling systems and methods

2009281809-Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions